TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Intellia Therapeutics Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Intellia Therapeutics Inc?
| Last request | 25.11.2023
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Intellia Therapeutics Inc is a biotechnology company focused on developing and commercializing gene editing therapies. |
| Most Notable Achievements | Intellia Therapeutics Inc has a strong pipeline of potential treatments for a variety of diseases. |
| The Most Negative Fact | Intellia Therapeutics Inc has yet to bring any of its treatments to market. |
| Competition | |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Intellia Therapeutics Inc?
| Request date | |
| Well Known | No |
| Description | Intellia Therapeutics Inc is a biotechnology company that develops gene editing therapies using CRISPR/Cas9 technology. |
| Most Notable Achievements | Intellia Therapeutics Inc has successfully developed a CRISPR/Cas9 therapy for a rare genetic disease called transthyretin amyloidosis, which has shown promising results in clinical trials. |
| The Most Negative Fact | Intellia Therapeutics Inc has faced legal challenges from other companies claiming patent infringement related to their use of CRISPR/Cas9 technology. |
| Competition | |
| Share with friends |
What does Google AI (PaLM) know about Intellia Therapeutics Inc?
| Last request | 23.12.2023 |
| Well Known | yes |
| Description | Intellia Therapeutics Inc. is a biotechnology company that develops gene-editing technologies. |
| Most Notable Achievements | The company's lead product candidate is Intellia 1901, a CRISPR-Cas9 gene-editing therapy for the treatment of sickle cell disease. |
| The Most Negative Fact | The company has been criticized for its high cost of gene-editing therapies. |
| Competition |
What does Microsoft Bing AI know about Intellia Therapeutics Inc?
| Well Known | No |
| Description | nepeh poaoido.ny iaIb ah zcevn ytcndsoiuelomdTcgancmnrol l Iiessofmnei nep airieagaeelitgnnsli i rhoegucte p c tditcge |
| Most Notable Achievements | areaeno. Tsetyhaslllp hne a ietarf a tanrttIiseoc stese oe iptoIi dncpviflntfgeomatpiss ure ni ar |
| The Most Negative Fact | spaToc ctI e of.ulkbe eaetihItamtna t y tels sntt mrs ryige tnoh itranrie n a |
| Competition | nedIdei na tEisiMcc |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
